Affinity Asset Advisors, LLC and Affinity Healthcare Fund, LP - Schedule 13G Filing

Affinity Asset Advisors, LLC, as the investment manager for Affinity Healthcare Fund, LP, has reported beneficial ownership of 862,400 shares of Forte Biosciences, Inc. common stock, representing 6.9% of the outstanding shares as of November 7, 2025. This ownership also includes the exercise of call options for an additional 22,400 shares. The filing indicates shared voting and disposition powers between the Advisor and the Fund. The filing asserts that these securities were not acquired or held with the purpose or effect of changing or influencing the control of the issuer.